Latest News & Features
Generics
UK-based cannabidiol lab sues firms behind proposed ANDA | Feud centres on a cannabis treatment for epilepsy. 19 January 2023
Biotechnology
Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas. 19 January 2023
Biotechnology
Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth. 12 January 2023
article
Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US. 12 January 2023
Big Pharma
Clarivate study highlights treatments with blockbuster potential | IV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer make the list | Nine blockbusters from China also predicted. 12 January 2023
Americas
Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma. 10 January 2023
article
German IP specialist gears up for UPC with experienced partner | Patent litigator previously led practice at IP boutique Meissner Bolte. 10 January 2023
Europe
‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies. 5 January 2023
Americas
Distributors and pharmacies face millions in damages and costs after selling international versions of Abbott products in the US | Fraud upon the court discovered after a court-authorised search of defendant’s premises seized an email server. 4 January 2023
Big Pharma
California-based company alleges competitor stole secrets following a collaboration bid | Complaint says Chinese competitor founded a sister company to develop rival treatment for metabolic disorders. 3 January 2023